| Effect of Oral Hygienization in Newborn on Candida Spp Colonization (NCT04410250) | Federal University of the Valleys of Jequitinhonha and Mucuri | 2019-11-01 |
| Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species (NCT03894839) | Yuzuncu Yil University | 2017-10-26 |
| Relationship Between Oral Hygiene in Newborns and Candida Spp. (NCT03873753) | Faculty Sao Leopoldo Mandic Campinas | 2017-05-02 |
| Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic (NCT02818803) | University of Sao Paulo | 2016-01-01 |
| Novel Rinse to Treat in Oral Candidiasis in Cancer Patients (NCT00612963) | Biomedical Development Corporation | 2007-04-01 |
| Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID (NCT00235053) | Allergy & Asthma Medical Group & Research Center | 2005-08-01 |
| Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis (NCT00665639) | Astellas Pharma Inc | 2004-06-01 |
| Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis (NCT00666185) | Astellas Pharma Inc | 2003-08-01 |
| A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis (NCT00128323) | Kamuzu University of Health Sciences | 2002-11-01 |
| Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis (NCT02184351) | Boehringer Ingelheim | 2001-05-01 |
| A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 (NCT00001812) | National Cancer Institute (NCI) | 1999-04-01 |
| Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients (NCT00002446) | Schering-Plough | 1998-08-01 |
| The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection (NCT00001448) | National Cancer Institute (NCI) | 1995-08-01 |
| Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups (NCT00004781) | National Institute of Dental and Craniofacial Research (NIDCR) | 1989-09-01 |
| A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush (NCT00000951) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes (NCT00002293) | Bristol-Myers Squibb | |
| A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole (NCT00001065) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients (NCT00002431) | Procter and Gamble | |
| Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome (NCT00002112) | Pfizer | |
| An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects. (NCT00002133) | Janssen, LP | |
| Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment (NCT00002394) | Novartis | |
| Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole (NCT00005920) | Merck Sharp & Dohme LLC | |
| A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS (NCT00002282) | Pfizer | |
| Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC (NCT00002057) | Bristol-Myers Squibb | |
| A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients (NCT00002399) | Schering-Plough | |
| A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole (NCT00002341) | Janssen, LP | |